ABSTRACT
INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver.
HCC accounts for about 90% of primary liver cancers and causes more than one million deaths worldwide per year [1] it ranks the 5th and 7th most common cancer among men and women [2] and the 4th in annular mortality rate [3] . There is a clear predominance of males worldwide, ranging from 8: 1 in countries with high incidence of HCC to approximately 2: 1 to 3: 1 in population with low frequency [4] .
Liver cancer incidence and mortality rates vary considerably across different geographical areas, with much of this variability related to the global distribution and natural history of infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) [5] . High incidences (more than 20 cases per 100.000 populations) are found in Eastern and South Eastern Asia, some of the western pacific islands, and eastern Africa [6] .
Chronic infection with HBV and HCV, aflatoxin ingestion and excessive alcohol consumption contribute to significant inter-country variations of incidence in hepatocellular carcinoma around the world. Although other factors, such as genetic/family history, diet and tobacco smoking, have been implicated in disease development, their contribution to disease causation remains uncertain [7, 8] .
People with chronic HBV or HCV infection are at 20 to 200-fold greater risk of developing HCC than those uninfected [9, 10] . According to a World Health Organization report published in 2004, an estimated two billion people worldwide were infected with HBV (with approximately 350 million chronically infected) and 170 million people were infected with HCV. Some 500,000 -1.2 million deaths each year are caused by HBV infection, with 320,000 deaths due to liver cancer [11] .
The overwhelming majority of HCC cases occur in patients with chronic liver disease [12] .
Approximately 80% have cirrhosis, and most of the remainder have moderate to advanced Fibrosis.
Cirrhosis of any cause can result in HCC, but chronic viral hepatitis accounts for more than 80 % of cases worldwide [13] .
Egypt shows one of the world's highest prevalence rates of HCV with about 10% prevalence of chronic HCV infection among persons aged 15-59 years [14] . The prevalence of HBsAg in Egypt is of intermediate endemicity (2%-8%) and nearly 2 to 3 million Egyptians are chronic carriers of HBV [15] .
In Egypt, 4.7 % of chronic liver disease patients suffer from HCC. The development of HCC is mainly due to high rates of hepatitis C and B infections among Egyptian patients [16] .
According to the report of the population-based cancer registry of Gharbiah , the incidence of liver cancer is ranked as the second highest in men and the seventh in women during 2000-2002 [17] . Moreover, there has been an alarming increase in incidence of liver cancer in Egypt, which is now three times higher than that in the USA [18] .
This study aims to identify the epidemiological and clinical characteristics of HCC patients 
STATISTICAL ANALYSIS
Data has been collected and entered to the computer using SPSS (Statistical Package for Social Science) program for statistical analysis, (version 17; Inc., Chicago. IL). Data from records was entered as numerical or categorical, as appropriate. Two types of statistics have been done: 1)
Descriptive statistics; where quantitative data was shown as mean, SD, and range, and qualitative data has been expressed as frequency and percent. 2) Analytical statistics: Chi-square test was used to measure association between qualitative variables, while Mann Whitney test have been used to compare mean and SD of 2 sets of quantitative not normally distributed data. P-value was considered statistically significant when it is less than 0.05.
RESULTS
The male to female ratio of the HCC patients was 2.9 :1, 74.4% were males (n=1116) while 25.6% were females (n=384), their ages ranged between 20 and 86 years with Mean ± SD equal to 54.98 ± 10.01 .More than half of patients were resident in urban areas (66.2%). Smoking have been reported in 42.2 % of patients (n=633), 6.86 % of patients (n=103) were found to be alcoholic, 49.73% were diabetic (n=746), 23.20 % were hypertensive (n=348), and 18.6 % were found to have history of Bilharziasis (n=279) {Table 1}. Nearly two thirds of patients were infected with Hepatitis C virus {Figure 1}.
The main complain among patients was the abdominal pain (76.8 %), and more than two thirds have been presented with hepatomegaly (87.2%), while ascites, jaundice and lower limb edema have been reported in 46.53 % of patients. More than half of patients (58.93%) have been diagnosed as having cirrhotic liver by Ultrasound. The size of the lesion was less than 2 centimeters in 48.2 % of patients and more than one third of lesions (44.2%) were present in right hepatic lobe. Multiple lesions and portal vein thrombosis were found in 51.26 %, 24.74 % of our patients respectively. Metastasis has been reported in 59.8 % of patients, nearly one third of patients got abdominal metastatic lesions (39 %) {Table 2}.
Regarding cirrhosis, 64.47 % of patients were Child-A classification (n=967), while 26.53 % were Child-B classification (n=398), and 9% were Child-C classification (n=135) with no significant difference between males and females (p>0.05). Received treatment line didn't differ significantly between male and female patients and it was mainly palliative therapy in 59.6 % of patients {Table 3}. No significant differences (p>0.05) have been found between male and female patients regarding Serum Glutamic-Oxaloacetic Transaminase, Serum Glutamic Pyruvic Transaminase, and Alfa Fetoprotein levels {Table 4}.
DISCUSSION
Hepatocellular carcinoma (HCC) is considered as one of the 130 major causes of morbidity and mortality in the world [20] .
In Egypt, Hepatocellular carcinoma is the second most common malignant tumor [21] accounting for about 7.2% of chronic liver disease patients [22] .
The prognosis of Hepatocellular carcinoma is generally grave [23] approximately 75% of patients with hepatocellular carcinoma present with advanced, unresectable disease with element of hepatic dysfunction [24] and in Egypt most patients presented in late stage in 85% of cases [21] . In this study, HCC has been commonly presented in males74.4% more than females 25.6% (male to female ratio is 2.9:1). This is in agreement with Kew [25] who concluded that male predominance is more obvious in population at high risk with male to female ratio 3.7:1 [25] however, other studies [26, 27] had pronounced male predominance of hepatocellular carcinoma through the world, ranging from male to female ratio 4:1 in low incidence areas and up to 9:1 in high incidence areas.
In Egypt, male predominance may be explained by the higher prevalence of viral hepatitis and high susceptibility to environmental carcinogens. In Egypt, especially in rural areas, males are more exposed to carcinogens and environmental factors as they participate more in outdoor activities than females. Also, androgenic hormones and increased genetic susceptibility may also increase risk among males [28] .
The mean age in the current study is 54.98 years, ranging from 20 years to 86 years. This is nearly similar to the age of 56 years found in other Egyptian studies [29, 30] .
The clinical picture of HCC is very variable [27] and dramatically different in different parts of the world [31] . In this study, the presenting symptoms mostly were abdominal pain, weight loss, abdominal enlargement and elevated body temperature. These results were constantly with that reported by Mohamed, et al. [32] . The prominent physical signs in our patients were hepatomegaly and hard liver, this goes in agreement with Di Bisceglie [33] who stated that, at physical examination the liver is often enlarged and may be hard [33] .
More than one third of our study patients have been reported to be smokers (42.2%). Badawi and Michael [34] stated that factors associated with an increased risk of HCC in Egypt were age over 60 years-old, farming, cigarette smoking and occupational exposure to chemicals such as pesticides Badawi and Michael [34] . El-Zayadi, et al. [22] reported that smoking yields chemicals with oncogenic potential that increase the risk of HCC 22 , however, the role of smoking was not clear in our study.
In this study, 69.8% of patients were found to be anti-HCV positive, while 17.2% were positive to HBsAg, 9.7% had mixed infection and 3.3% were free of infection.
El-Zayadi, et al. [22] reported the proportions of HCV antibodies and HBsAg among HCC cases were 86.9% and 28.4% respectively El-Zayadi, et al. [22] . While, Abdel-Wahab, et al. [35] reported that the proportion of HCV were 79.6%, HBV 6.9% and among them 3.6% with mixed hepatitis B and C virus markers, while 17.1% were negative for HCV and HBV markers [35] .
This could be attributed to the high prevalence of chronic HCV infection among general
Egyptian population which has been estimated to be approximately 10% among persons aged 15-59 years [14] .
This study shows that 18.6 % of cases have history of Bilharziasis. Hassan, et al. [36] ; ElZayadi, et al. [22] concluded that both HCV and HBV infection increase risk of HCC in Egyptian patients, whereas isolated schistosomal infection does not [22, 36] .
In the current study, most of the patients with HCC (64.47%) were Child I, followed by Child II (26.53%) then Child III (9 %). This is in agreement with study of Mohamed, et al. [32] who reported that (49.5%) of cases were Child I, followed by Child II (47.5%) then Child III (3%) [23] but this is not in agreement with Rex [37] who reported that most HCC (60-70%) are diagnosed at an advanced stage [37] .
The right lobe was predominantly more affected (44.2%) than left lobe (23.1%) in the this study. This is in agreement with Rosen and Nagorney [38] who stated that HCC occurs most frequently in the right hepatic lobe [38] .
El-Zayadi, et al. [22] reported that 70.9% of lesions were in the right lobe and 81% of lesions smaller than 3 cm [22] .
CONCLUSION
The current study showed that most of HCC patients who have been presented to the Oncology unit at Menofia University hospitalin the duration from 2003-2012 were of male gender, infected with HCV and/or HBV, and of advanced stage at presentation, which raise the issue of the importance of developing screening programs for early detection of HCC in high risk patients at a national level and searching for new approaches in management; which will definitely improve the patient outcome. Health education programmes are needed to raise the awareness of publics about the modes of transmission and risks of hepatitis B and C.
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